Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404180 · ClinicalTrials.gov registry record · Phase 4
Peripheral Nerve Blocks for Above-the-knee Amputations
A Phase 4 study of Hypertension and Coronary Artery Disease, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03404180: Completed Phase 4 study of Hypertension and Coronary Artery Disease, sponsored by University of Florida.
NCT03404180 is a Phase 4 study of Hypertension and Coronary Artery Disease that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03404180, a Phase 4 study of Hypertension and Coronary Artery Disease, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Surgery performed with nerve blocks and sedation may be safer and provide better pain control compared to general anesthesia and opioid therapy in high-risk patient populations such as elderly and troubled with peripheral vascular disease, diabetes, hypertension, coronary artery disease, and chronic obstructive pulmonary disease (COPD).
Conditions Studied
Interventions
- PROCEDURE Peripheral nerve block
- DRUG Intravenous Sedatives
- PROCEDURE Lateral femoral cutaneous nerve blocks
- PROCEDURE Obturator nerve blocks
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-02-09 |
| Est. Completion | 2024-12-18 |
| Phase | Phase 4 |
What the finished NCT03404180 record still lists
NCT03404180 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Hypertension appearing as the primary indexed condition, and to 4 interventions - of which Peripheral nerve block is the first listed.
NCT03404180 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03404180 about?
NCT03404180 is a clinical study titled "Peripheral Nerve Blocks for Above-the-knee Amputations". Surgery performed with nerve blocks and sedation may be safer and provide better pain control compared to general anesthesia and opioid therapy in high-risk patient populations such as elderly and troubled with peripheral vascular disease, diabetes, hypertension, coronary artery disease, and chronic...
What is the current status of trial NCT03404180?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2018-02-09. Estimated completion is 2024-12-18.
What conditions does trial NCT03404180 study?
This clinical trial studies the following conditions: Hypertension, Coronary Artery Disease, Pulmonary Disease, Chronic Obstructive, Peripheral Vascular Diseases, Hyperglycaemia (Diabetic).
What interventions are being tested in trial NCT03404180?
The interventions under investigation include: Peripheral nerve block (PROCEDURE), Intravenous Sedatives (DRUG), Lateral femoral cutaneous nerve blocks (PROCEDURE), Obturator nerve blocks (PROCEDURE).
Who is sponsoring clinical trial NCT03404180?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03404180 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03404180's enrollment target sits among peer trials
30 408th of 470 higher than 54 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
RECRUITING · Phase 4
-
Bridging the Evidence-to-practice Gap
RECRUITING · Phase 4
-
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
RECRUITING · Phase 4
-
Secondhand Tobacco Smoke and Cardiovascular Disease
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI